Successful relationships from flexible approachWe provide extensive custom radiolabelling, chemistry and analytical services to many industry sectors throughout the world

Newsletter Sign-up

Selcia Newsletter delivered
direct to your Inbox

Please sign me up for occasional news updates from Selcia. Privacy Policy

Submit >

Pharmaceutical and Biotechnology Industry

Selcia has extensive expertise in radiolabelling small molecule drugs for drug metabolism, pre-clinical and pharmacokinetic studies. Our chemists have many years experience working in big pharma and we provide overflow capacity to internal isotope groups and synthesise radiolabelled API using GMP concepts for mass balance and microdosing studies. Our analytical group has expertise in using high field NMR to identify  impurities and to ensure the material is suitable for the intended study. We also have experience radiolabelling pharmaceuticals for environmental fate studies.

C-14 Custom radiolabelling | Radiolabelled API to GMP Concepts | Partnering and outsourcing | Techniques and equipment

25 April 2012

Selcia showcased in sp2 Magazine

Sp2 Magazine has published an article in its recent issue showcasing Selcia's successful Drug Discovery and Radiolabelling divisions.

18 April 2012

Selcia and Heptares Therapeutics Announce New Fragment Screening Collaboration

Selcia and Heptares Therapeutics Announce New Fragment Screening Collaboration